Stocks Hitting 52-Week Lows - Alnylam Pharmaceuticals (NASDAQ:ALNY), Buckle (NYSE:BKE)

Alnylam Pharmaceuticals, Inc. ALNY shares fell 49.4 percent to touch a new 52-week low of $35.55 after the company disclosed that it has decided to discontinue the Revusiran development. Leerink Swann downgrades Alnylam Pharmaceuticals from Outperform to Market Perform and lowered the price target from $107.00 to $40.00, while Barclays also downgraded the stock from Overweight to Equal-weight and lowered the price target from $85.00 to $50.00.
Cato Corp CATO shares dropped 9.4 percent to touch a new 52-week low of $29.87. Cato reported 9 percent drop in same-store sales for September while net sales fell 8 percent from $83.2 million to $76.2 million in September. As a result, the company slashed its EPS forecast from $0.13–$0.18 to $0.07–$0.11 for the third quarter.
Buckle Inc BKE shares fell 9.4 percent to reach a new 52-week low of $21.43. Buckle revealed 15.5 percent drop in comparable store sales while net sales fell 14.8 percent from $97.4 million to $82.9 million.
BT Group plc (ADR) BT shares touched a new 52-week low of $23.78. BT Group shares have declined 25.33 percent over the past 52 weeks, while the S&P 500 index has gained 9.08 percent in the same period.